Clinical Trials List
2023-12-28 - 2029-12-31
Phase III
Recruiting6
ICD-10D63.1
Anemia in chronic kidney disease
ICD-9285.21
Anemia in end-stage renal disease
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yueh-Lin Wu Division of Nephrology
- Chung-Te Liu Division of Nephrology
- Chung-Yi Cheng Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- I-jen Chiu Division of Nephrology
- YUNG-HO HSU Division of Nephrology
- Mei-Yi Wu Division of Nephrology
- 洪冠予 Division of Nephrology
- Chia-Te Liao Division of Nephrology
- Mai-Szu Wu Division of Nephrology
- Li-Yee Hong Division of Nephrology
- Cai-Mei Zheng Division of Nephrology
- 林冠宏 Division of Nephrology
- 高芷華 Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chih-Chin Kao Division of Nephrology
- Hsi-Hsien Chen Division of Nephrology
- Te-Chao Fang Division of Nephrology
- 陳靜怡 Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
32 participants
-
Global
429 participants
